2012•Journal of Diseases Monitor & ControlRequires access

The Combination of Inhaled Budesonide/Formoterol and Ambroxol in Treatment of Acute Exacerbations of Chronic Obstructive Pulmonary Disease

Guoliang Zhang

Open publisher page 0 citations

Abstract

Objective To investigate the effect of combination therapy with inhaled budesonide /formoterol and ambroxol on the acute exacerbations of chronic obstructive pulmonary disease(AECOPD).Methods 84 subjects with AECOPD were randomly divided into 3 groups:the control group(C group, n=28),the Budesonide/ formoterol group(B group,n=28),and the Budesonide/ formoterol and ambroxol group(A group,n=28).Compare the difference of 3 groups at the pulmonary function(FEV_1,FEV_1%、FEV_1/FVC) and the scores of SGRQ before and after the therapy.Results The pulmonary function and the scores of SGRQ in 3 groups after the therapy were improved in evidence(P0.05).Compared with control group,significantly greater improvements were seen in B group and A group(P0.05).And A group were slightly better than B group(P0.05).Conclusions This study demonstrated that combination treatment with budesonide/formoterol plus ambroxol is an effective methods in the management of AECOPD.

About this research paper

What this paper is about

Objective To investigate the effect of combination therapy with inhaled budesonide /formoterol and ambroxol on the acute exacerbations of chronic obstructive pulmonary disease(AECOPD).Methods 84 subjects with AECOPD were randomly divided into 3 groups:the control group(C group, n=28),the Budesonide/ formoterol group(B group,n=28),and the Budesonide/ formoterol and ambroxol group(A group,n=28).Compare the difference of 3 groups at the pulmonary function(FEV_1,FEV_1%、FEV_1/FVC) and the scores of SGRQ before and after the therapy.Results The pulmonary function and the scores of SGRQ in 3 groups after the therapy were improved in evidence(P0.05).Compared with control group,significantly greater improvements were seen in B group and A group(P0.05).And A group were slightly better than B group(P0.05).Conclusions This study demonstrated that combination treatment with budesonide/formoterol plus ambroxol is an effective methods in the management of AECOPD.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the effect of combination therapy with inhaled budesonide /formoterol and ambroxol on the acute exacerbations of chronic obstructive pulmonary disease(AECOPD).Methods 84 subjects with AECOPD were randomly divided into 3 groups:the control group(C group, n=28),the Budesonide/ formoterol group(B group,n=28),and the Budesonide/ formoterol and ambroxol group(A group,n=28).Compare the difference of 3 groups at the pulmonary function(FEV_1,FEV_1%、FEV_1/FVC) and the scores of SGRQ before and after the therapy.Results The pulmonary function and the scores of SGRQ in 3 groups after the therapy were improved in evidence(P0.05).Compared with control group,significantly greater improvements were seen in B group and A group(P0.05).And A group were slightly better than B group(P0.05).Conclusions This study demonstrated that combination treatment with budesonide/formoterol plus ambroxol is an effective methods in the management of AECOPD.

Key concepts: Medicine, Budesonide, Formoterol, Ambroxol, Budesonide/formoterol, Pulmonary function testing, Pulmonary disease, Anesthesia

Related papers

Back to paper searchBrowse research topicsOriginal source
The Combination of Inhaled Budesonide/Formoterol and Ambroxol in Treatment of Acute Exacerbations of Chronic Obstructive Pulmonary Disease — Research Paper | ScholarLens